Men's values-based factors on prostate cancer risk genetic testing: A telephone survey

BMC Medical Genetics

Volumn 5, Issue , 2004, Pages

  Doukas, David J ^a   Li, Yuelin ^b,c  

^a University of Louisville School of Medicine   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER RISK; CITY; COMPUTER SYSTEM; CONTROLLED STUDY; CORRELATION FUNCTION; DISTRESS SYNDROME; EXPECTATION; FACTORIAL ANALYSIS; GENETIC SCREENING; HEALTH BEHAVIOR; HEALTH SURVEY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MOTIVATION; PROSTATE CANCER; PSYCHOMETRY; RATING SCALE; STATISTICAL ANALYSIS; TELEPHONE; UNITED STATES; CAUCASIAN; EDUCATIONAL STATUS; GENETIC PREDISPOSITION; HISPANIC; METHODOLOGY; MIDDLE AGED; NEGRO; PATIENT ATTITUDE; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT; RISK FACTOR; SOCIOECONOMICS; STATISTICS;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; EDUCATIONAL STATUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PROSTATIC NEOPLASMS; PSYCHOMETRICS; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 26444540431     PISSN: 14712350     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-5-28     Document Type: Article

References (30)

1. Lerman C, Hughes C, Benkendorf JL, Biesecker B, Kerner J, Willison J, Eads N, Hadley D, Lynch J: Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing. Cancer Epidemiol Biomarkers Prev 1999, 8:361-367.
2. Myers RE, Hyslop T, Jennings-Dozier K, Wolf TA, Burgh DY, Diehl JA, Lerman C, Chodak GW: Intention to be tested for prostate cancer risk among African-American men. Cancer Epidemiol Biomarkers Prev 2000, 9:1323-1328.
3. Lerman C, Daly M, Masny A, Balshem A: Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 1994, 12:843-850.
4. Miesfeldt S, Jones SM, Cohn W, Lippert M, Haden K, Turner BL, Martin-Fries T, Clark SM: Men's attitudes regarding genetic testing for hereditary prostate cancer risk. Urology 2000, 55:46-50.
5. Chaliki H, Loader S, Levenkron JC, Logan-Young W, Hall WJ, Rowley PT: Women's receptivity to testing for a genetic susceptibility to breast cancer. Am J Public Health 1995, 85:1133-1135.
6. Durfy SJ, Bowen DJ, McTiernan A, Sporleder J, Burke W: Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiol Biomarkers Prev 1999, 8:369-375.
7. Tambor ES, Rimer BK, Strigo TS: Genetic testing for breast cancer susceptibility: Awareness and interest among women in the general population. Am J Med Genet 1997, 68:43-49.
8. Andrykowski MA, Munn RK, Studts JL: Interest in learning of personal genetic risk for cancer: A general population survey. Prev Med 1996, 25:527-536.
9. Graham ID, Logan DM, Hughes-Benzie R, Evans WK, Parras H, McAuley LM, Laupacis A: How interested is the public in genetic testing for colon cancer susceptibility? Report of a cross-sectional population survey. Cancer Prev Control 1995, 2:167-172.
10. Lerman C, Hughes C, Trock BJ, Myers RE, Main D, Bonney A, Abbaszadegan MR, Harty AE, Franklin BA, Lynch JF, Lynch HT: Genetic testing in families with hereditary nonpolyposis colon cancer. JAMA 1999, 281:1618-1622.
11. Smith JR, Freije D, Carpten JD, Gronberg H, Xu J, Isaacs SD, Brownstein MJ, Bova GS, Guo H, Bujinovszky P, Nusskern DR, Damber JE, Bergh A, Emanuelsson M, Kallioniemi OP, Walker-Daniels J, Bailey-Wilson JE, Beaty TH, Meyers DA, Walsh PC, Collins FS, Trent JM: Major susceptibility locus for prostate cancer on Chromosome I suggested by genome-wide search. Science 1996, 274:1371-1374.
12. Gronberg H, Xu J, Smith JR, Carpten JD, Isaacs SD, Freije D, Bova GS, E. DJ, Bergh A, Walsh PC, Collins FS, Trent JM, Myers DA, Isaacs WB: Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPc1) on Chromosome I. Cancer Res 1997, 57:4707-4709.
13. Ponder B: Genetic testing for cancer risk. Science 1997, 278:1050-1054.
14. Bratt O: Hereditary prostate cancer: Clinical aspects. J Urol 2002, 168:906-913.
15. Doukas DJ, Fetters MD, Coyne JC, McCullough LB: How men view genetic testing for prostate cancer risk: Findings from focus groups. Clin Genet 2000, 58:169-176.
16. Tabachnick BG, Fidell LS: Using multivariate statistics. 3rd edition. New York, NY: HarperCollins College Publishers; 1996.
17. Devellis RF: Scale development. Theory and applications. Newbury Park, CA: Sage Publications, Inc; 1991.
18. Stewart DA, Love W: A general canonical index. Psychol Bull 1968, 70:160-163.
19. Comrey AL, Lee HB: A first course in factor analysis. 2nd edition. Hillsdale, NJ: Erlbaum; 1992.
20. Doukas DJ, Localio R, Li Y: Attitudes and beliefs concerning prostate cancer genetic screening. Clin Genet 2004, 66:445-451.
21. Lynch HT, Lemon SJ, Durham C, Tinley ST, Connolly C, Lynch JF, Surdam J, Orinion E, Slominski-Caster S, Watson P, Lerman C, Tonin P, Lenoir G, Serova O, Narod S: A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer 1997, 79:2219-2228.
22. Li Y, Doukas DJ: Health motivation and emotional vigilance in genetic testing for prostate cancer risk. Clin Genet 2004, 66:512-516.
23. Capelli M, Surh L, Humphreys L, Verma S, Logan D, Hunter A, Allanson J: Psychological and social determinants of women's decision to undergo genetic counseling and testing for breast cancer. Clin Genet 1999, 55:419-430.
24. Codori AM, Petersen GM, Miglioretti DL, Larkin EK, Bushey MT, Young C, Brensinger JD, Johnson K, Bacon JA, Booker SV: Attitudes toward colon cancer gene testing: factors predicting test uptake. Cancer Epidemiol Biomarkers Prev 1999, 8:345-351.
25. Vernon SW, Gritz ER, Peterson SK, Perz CA, Marani S, Amos CI, Baile WF: Intention to learn results of genetic testing for hereditary colon cancer. Cancer Epidemiol Biomarkers Prev 1999, 8:353-360.
26. Stanley AJ, Gaff CL, Aittomaki AK, Fabre LC, Macrae FA, St John J: Value of predictive genetic testing in management of hereditary non-polyposis colorectal cancer (HNPCC). Med J Aust 2000, 172:313-316.
27. de la Chapelle A, Kaarianinen H: Predicting genetic testing for hereditary non-polyposis colorectal cancer: Uptake and long-term satisfaction. Int J Cancer 2000, 89:44-50.
28. Reichelt JG, Dahl AA, Heimdal K, Moller P: Uptake of genetic testing and pre-testing levels of mental distress in Norwegian families with known BRCA1 mutations. Dis Markers 1999, 15:139-143.
29. Evans DG, Maher ER, Macleod R, Davies DR, Craufurd D: Uptake of genetic testing for cancer predisposition. J Med Genet 1997, 34:746-748.
30. Doukas DJ: Genetics providers and the family covenant: Connecting individuals with their families. Genet Test 2003, 7:315-321.